aneurysm closure device
By setting openings at the proximal and distal ends of the support body of the aneurysm closure device and indenting the closure component inward during implantation, a double-layer closure is achieved, solving the problems of high cost and high risk in the treatment of aneurysms in the prior art, improving the closure effect and reducing the complexity of operation.
Patent Information
- Application Number
- CN202522685719.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-18
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2035-12-18
AI Technical Summary
Existing treatments for intracranial aneurysms, such as coil embolization, stent-assisted coil embolization, and flow diversion devices, have drawbacks including long operation time, high cost, high risk, the need for long-term use of antiplatelet drugs, and difficulty in completely sealing the aneurysm neck.
An aneurysm occlusion device was designed, comprising a radially expandable mesh support body and an occlusion component. The support body has openings at its proximal and distal ends. When implanted, the occlusion component seals the openings and is recessed into the support body to achieve double-layer occlusion, thus preventing the occlusion component from touching the aneurysm or affecting the blood flow of the aneurysm-bearing artery.
It improves the effectiveness of aneurysm closure, avoids the risks of aneurysm rupture and thrombosis in the parent artery, simplifies the procedure, and reduces treatment costs.
Smart Images

Figure CN224974876U_ABST
Abstract
Description
Technical Field
[0001] This utility model relates to the field of medical device technology, and in particular to an aneurysm closure device. Background Technology
[0002] Intracranial aneurysms are abnormal bulges that gradually expand due to local damage to the vessel wall caused by congenital or acquired factors, under the influence of hemodynamic load and other factors.
[0003] Treatment for intracranial aneurysms typically involves two methods: open craniotomy clipping and interventional therapy. With the continuous advancement of neurointerventional techniques in recent years, interventional therapy has gradually replaced traditional surgery, playing an irreplaceable role in the treatment of intracranial aneurysms.
[0004] Currently, coil embolization, stent-assisted coil embolization, flow diverters, and intracranial flow diverters have become typical instruments for treating aneurysms. Coil embolization is the most widely used aneurysm treatment method in clinical practice. For large aneurysms, multiple coils need to be implanted, resulting in a long operation time, high cost, and increased risks due to the need for multiple procedures. Stent-assisted coil embolization is costly due to the need to deliver both the stent and coils, is complex for doctors, and requires patients to take antiplatelet drugs long-term. After implantation of flow diverters, patients also need to take antiplatelet drugs long-term, as they can cause occlusion of branch vessels. Intracranial flow diverters are difficult to completely seal the aneurysm neck.
[0005] In view of this, it is necessary to provide an aneurysm occlusion device to solve the above-mentioned technical problems. Utility Model Content
[0006] To achieve the above objectives, this utility model provides an aneurysm occlusion device, which has a delivery state and an implantation state. It includes a support body, which is a radially expandable mesh structure, with openings at the proximal and distal ends of the support body; two occlusion members are respectively connected to the proximal and distal ends of the support body; when the aneurysm occlusion device is in the implantation state, the occlusion members block the corresponding openings, and the occlusion members are recessed into the interior of the support body.
[0007] As a further improvement of this utility model, both of the sealing components adopt a braided structure; or, both of the sealing components adopt a spring coil structure; or, one of the two sealing components adopts a braided structure and the other adopts a spring coil structure.
[0008] As a further improvement of this utility model, the braided structure includes a first connecting end connected to the corresponding opening and a gathering end opposite to the first connecting end, and the braided structure gradually gathers from the first connecting end to the gathering end; When the aneurysm closure device is in the delivery state, the braided structure is located inside the support body.
[0009] As a further improvement of this utility model, the spring coil structure includes a helical coil and a secondary helical spring coil wound around the helical coil. The helical coil includes a second connecting end connected to the corresponding opening and a free end opposite to the second connecting end. When the aneurysm closure device is in the delivery state, the spring coil structure is located outside the support body, and the spiral coil is in a straightened state.
[0010] As a further improvement of this utility model, when the aneurysm is in the implanted state, the maximum outer diameter of the spiral coil is greater than the inner diameter of the corresponding opening.
[0011] As a further improvement of this utility model, it also includes a developing beam ring coaxially disposed with the support body, the developing beam ring being connected to the end of the sealing member away from the corresponding opening.
[0012] As a further improvement of this utility model, when the aneurysm occlusion device is in the implanted state, the ratio of the recess depth of the occlusion member to the height of the support body is 1 / 5 to 2 / 5.
[0013] As a further improvement of this utility model, the support body includes a first part and a second part located at the proximal end of the first part. When the aneurysm occlusion device is in the implanted state, from the proximal end to the distal end of the support body, the outer diameter of the second part gradually increases, the outer diameter of the first part gradually decreases, and the height of the first part is less than the height of the second part.
[0014] As a further improvement of this utility model, when the aneurysm closure device is in the implanted state, the ratio of the height of the first part to the maximum outer diameter of the support body is 1 / 8 to 1 / 6; the ratio of the height of the second part to the maximum outer diameter of the support body is 1 / 4 to 3 / 8.
[0015] As a further improvement of this utility model, the support body is formed by braiding filaments, the braiding filaments including a nickel-titanium tube and a developing filament located inside the nickel-titanium tube; or, the braiding filaments are made of nickel-titanium wire and developing filaments; The supporting body has a plurality of braided endpoints surrounding the opening, and the aneurysm occlusion device further includes a radiopaque ball disposed at the braided endpoints.
[0016] The beneficial effects of this invention are as follows: By providing openings at the proximal and distal ends of the support body, it is convenient to connect the occlusion components at the proximal and distal ends of the support body. Furthermore, when the aneurysm occlusion device is implanted, the occlusion components can be recessed into the support body without obstruction. By simultaneously providing occlusion components at the proximal and distal ends of the support body, after the aneurysm occlusion device is implanted into the aneurysm, both the proximal and distal openings of the support body are sealed by the occlusion components, thus achieving double-layer occlusion to prevent blood from flowing into the aneurysm and improving the occlusion effect. The distal occlusion component is recessed into the support body, thus preventing it from touching and puncturing the aneurysm, thereby protecting the aneurysm from rupture. The proximal occlusion component is recessed into the support body, thus preventing it from protruding into the carrier artery. The proximal occlusion component does not affect the blood flow direction in the carrier artery, thus preventing thrombus formation and the risk of vascular blockage. Attached Figure Description
[0017] The accompanying drawings, which are included to provide a further understanding of the present invention and constitute a part of this invention, illustrate exemplary embodiments of the present invention and, together with the description thereof, serve to explain the present invention and do not constitute an undue limitation thereof. In the drawings: Figure 1 This is a schematic diagram of an embodiment of the aneurysm occlusion device of this utility model; Figure 2 for Figure 1 Exploded view; Figure 3 This is a schematic diagram of an embodiment of the aneurysm closure device of this utility model in the implantation state; Figure 4 for Figure 3 The diagram shows the aneurysm closure device in the delivery state; Figure 5 This is a schematic diagram of another embodiment of the aneurysm closure device of this utility model in the implantation state; Figure 6 for Figure 5 The diagram shows the aneurysm closure device in the delivery state; Figure 7 This is a schematic diagram of another embodiment of the aneurysm closure device of this utility model in the implantation state; Figure 8 for Figure 7 The diagram shows the aneurysm closure device in the delivery state; Figure 9 This is a schematic diagram of another embodiment of the aneurysm closure device of this utility model in the implantation state; Figure 10 for Figure 9The diagram shows the aneurysm closure device in the delivery state; Figure 11 This is a schematic diagram of the supporting body in this utility model; Figure 12 This is a schematic diagram of the braided structure in this utility model; Figure 13 This is a schematic diagram of the spring coil structure in this utility model; In the picture: 10. Support body; 11. Opening; 12. First part; 13. Second part; 20. Sealing component; 21. Braided structure; 211. First connecting end; 212. Closing end; 22. Spring coil structure; 221. Helical coil; 222. Secondary helical spring coil; 30. Developing bundle ring; 40. Developing ball. Detailed Implementation
[0018] To make the objectives, technical solutions, and advantages of this utility model clearer, the technical solutions of this utility model will be clearly and completely described below in conjunction with specific embodiments and corresponding drawings. Obviously, the described embodiments are only a part of the embodiments of this utility model, and not all of them. Based on the embodiments of this utility model, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of this utility model.
[0019] In the description of this utility model, unless otherwise specified and limited, it should be noted that the terms "installation", "connection" and "linking" should be interpreted broadly. For example, they can refer to mechanical or electrical connections, or internal connections between two components. They can be direct connections or indirect connections through an intermediate medium. Those skilled in the art can understand the specific meaning of the above terms according to the specific circumstances.
[0020] The terms used in this application to describe position and direction are all relative to the operator of the device, with the end closer to the operator being the proximal end and the end farther from the operator being the distal end.
[0021] like Figures 1 to 13 As shown, this utility model provides an aneurysm closure device. The aneurysm protrudes outward from the side wall of the patient's blood vessel. When treating the patient's aneurysm, the aneurysm closure device is implanted into the aneurysm. At this time, the distal end of the aneurysm closure device is close to the top of the aneurysm, and the proximal end is close to the neck of the aneurysm, so as to block the aneurysm.
[0022] The aneurysm closure device has a delivery state and an implantation state. It includes a support body 10 and two closure members 20. The support body 10 is a radially expandable mesh structure. The proximal and distal ends of the support body 10 have openings 11. The closure members 20 are connected to the proximal and distal ends of the support body 10. When the aneurysm closure device is in the implantation state, the closure members 20 block the corresponding openings 11 and the closure members 20 are recessed into the interior of the support body 10.
[0023] The support body 10 has a proximal opening at its proximal end and a distal opening at its distal end. For ease of description, the sealing member 20 connected to the proximal opening is referred to as the proximal sealing member, and the sealing member 20 connected to the distal opening is referred to as the distal sealing member.
[0024] When the aneurysm closure device is in the delivery state, the support body 10 and the two closure components 20 are in a contracted or elongated state. When the aneurysm closure device is in the implantation state, the support body 10 expands to fit against the inner wall of the aneurysm, thereby fixing the aneurysm closure device within the aneurysm. At the same time, the closure components 20 block the corresponding openings 11, that is, the proximal closure component blocks the proximal opening of the support body 10, and the distal closure component blocks the distal opening of the support body 10, so as to prevent blood from flowing into the aneurysm.
[0025] By providing openings 11 at the proximal and distal ends of the support body 10, it is convenient to connect the occlusion member 20 at the proximal and distal ends of the support body 10, and when the aneurysm occlusion device is implanted, the occlusion member 20 can be recessed into the interior of the support body 10 without obstruction. The support body 10 only serves a supporting and fixing function, so the mesh structure density of the support body 10 does not need to be too dense, thereby reducing the radial force and pushing resistance when pushing the support body 10, and pushing can be achieved using a microcatheter with a small inner diameter.
[0026] By simultaneously providing occlusion components 20 at both the proximal and distal ends of the support body 10, after the aneurysm occlusion device is implanted into the aneurysm, the openings 11 at both the proximal and distal ends of the support body 10 are sealed by the occlusion components 20, thereby achieving double-layer occlusion to prevent blood from flowing into the aneurysm and improving the occlusion effect. The distal occlusion component is recessed into the support body 10, thereby preventing the distal occlusion component from touching and puncturing the aneurysm, thus protecting the aneurysm from rupture. The proximal occlusion component is recessed into the support body 10, thereby preventing the proximal occlusion component from protruding into the carrier artery. The proximal occlusion component will not affect the blood flow direction in the carrier artery, and therefore will not form a thrombus in the carrier artery, thus avoiding the risk of vascular blockage.
[0027] Specifically, when the aneurysm closure device is located inside the guide sheath or microcatheter, the aneurysm closure device is in a delivery state, and the support body 10 and the closure component 20 are subject to radial restraint force. At this time, the support body 10 and the closure component 20 are in a contracted or elongated state. After the aneurysm closure device is implanted into the aneurysm, the support body 10 is detached from the guide sheath or microcatheter, the support body 10 is no longer restrained and expands, the distal end of the support body 10 is close to the aneurysm top, and the proximal end is close to the aneurysm neck. The shape of the support body 10 in the implanted state is the initial shape of the support body 10. The openings 11 at the proximal and distal ends of the support body 10 are sealed by the closure component 20 to prevent blood from flowing into the aneurysm.
[0028] The support body 10 serves as a basket to fix the aneurysm closure device within the aneurysm. The support body 10 is formed by braiding filaments, with the number of filaments ranging from 12 to 36. The support body 10 is visualized using transillumination, allowing observation of its implantation position within the aneurysm.
[0029] The braided wire can be a nickel-titanium tube combined with a radiopaque wire, with the radiopaque wire located inside the nickel-titanium tube. The nickel-titanium alloy material forming the nickel-titanium tube has superelasticity and shape memory function, allowing the support body 10 to automatically return to its initial shape after implantation into the aneurysm; simultaneously, the nickel-titanium alloy material is also a biocompatible material and is relatively safe. The radiopaque wire is a platinum-tungsten radiopaque wire, which is sufficiently flexible to deform along with the nickel-titanium tube; the platinum-tungsten radiopaque wire has radiopaque properties under DSA equipment, thus enabling the radiopaque positioning of the support body 10 to be located. The outer diameter of the nickel-titanium tube is 0.05mm~0.1mm, and the inner diameter is 0.03~0.08mm; the outer diameter of the platinum-tungsten radiopaque wire is 0.01mm~0.05mm.
[0030] The braided wire can also be made of nickel-titanium wire and developing wire. Specifically, the braided wire is a round wire, which is formed by welding nickel-titanium wire with a semi-circular cross section and platinum-tungsten developing wire; or the braided wire is formed by spirally winding nickel-titanium wire and developing wire into a twisted shape.
[0031] The support body 10 includes a first part 12 and a second part 13 located at the proximal end of the first part 12. When the aneurysm closure device is implanted, from the proximal end to the distal end of the support body 10, the outer diameter of the second part 13 gradually increases, the outer diameter of the first part 12 gradually decreases, and the height of the first part 12 is less than the height of the second part 13, that is, the first part 12 and the second part 13 are asymmetrically arranged.
[0032] When the aneurysm closure device is implanted, the support body 10 is frustum-shaped, allowing it to fit snugly against the inner wall of the aneurysm and preventing displacement after implantation. Since aneurysms are irregularly shaped and some are relatively short, the height of the first part 12 is adaptively reduced to prevent its tip from touching and puncturing the aneurysm. Simultaneously, to ensure the stability of the support body 10 after implantation, the height of the second part 13 is greater than that of the first part 12. The second part 13 provides stable support for the aneurysm closure device and ensures secure fixation after implantation, thereby improving the versatility of the aneurysm closure device.
[0033] The maximum outer diameter Dmax of the implanted support body 10 is 2mm~20mm, such as 2mm, 4mm, 7mm, 10mm, 15mm, 20mm, etc., which can meet the size requirements of various aneurysms.
[0034] The ratio of the height H1 of the first part 12 to the maximum outer diameter Dmax of the support body 10 is 1 / 8 to 1 / 6, and the ratio of the height H2 of the second part 13 to the maximum outer diameter Dmax of the support body 10 is 1 / 4 to 3 / 8. The specific ratio can be selected according to the adaptability of different narrow-necked and wide-necked aneurysms.
[0035] The fabrication process of the support body 10 includes weaving, heat setting, sandblasting, and electrochemical polishing. Specifically, nickel-titanium tubes or wires are woven along the axis on the outer surface of a mandrel using a 12-36 spindle weaving machine to form the support body 10. The heat setting operation requires supporting the support body 10 internally using a setting fixture and placing it in a protective gas furnace for high-temperature heating. At high temperatures, the material maintains the desired shape, requiring at least two setting operations. The setting temperature is 380-680℃, and the setting time is 15-30 minutes. After setting, the support body 10 needs surface polishing, which can be achieved through surface sandblasting or electrolytic treatment. In one possible approach, a sandblasting machine is used to sandblast the surface of the support body 10 to remove impurities, burrs, and oxide layers from the sealing bracket surface. Under a pressure of 30-80 psi, abrasives with a particle size of 5-30 μm, such as alumina, are used to orient the support body 10, removing the oxide layer and improving the surface quality of the support body. In one possible implementation, the support body 10 is electrolyzed in an electrochemical polishing device to achieve a mirror finish. For example, the polishing solution temperature is 46-76°C, and the voltage is 10-30V. The support body 10 is then cleaned using an ultrasonic cleaner with water for injection or anhydrous ethanol as the cleaning medium. The cleaning time is 10-30 minutes, and the temperature is room temperature. Finally, if a nickel-titanium tube is used, a platinum-tungsten developing wire is inserted into the nickel-titanium tube; if a nickel-titanium wire is used, the platinum-tungsten developing wire is welded to the nickel-titanium wire. To further improve the strength of the weld between the nickel-titanium wire and the platinum-tungsten developing wire, a coating treatment can be performed.
[0036] When the aneurysm closure device is implanted, the ratio of the closure member 20 to the depression depth H3 to the height H of the supporting body 10 is 1 / 5 to 2 / 5. The depression depth of the closure member 20 should not be too small to completely prevent the closure member 20 from touching the aneurysm or affecting the blood flow in the aneurysm-bearing artery; the depression depth of the closure member 20 should not be too large to avoid mutual interference between the proximal and distal closure members.
[0037] The occlusion component 20 employs a braided structure 21 or a spring coil structure 22 to block the proximal or distal opening of the supporting body 10, thereby preventing blood from flowing into the aneurysm. The proximal and distal occlusion components can be the same or different; that is, both the proximal and distal occlusion components can employ a braided structure 21 or a spring coil structure 22; or, one of the proximal and distal occlusion components can employ a braided structure 21, and the other can employ a spring coil structure 22.
[0038] The braided structure 21 includes a first connecting end 211 connected to the corresponding opening 11 and a gathering end 212 opposite to the first connecting end 211. The braided structure 21 gradually converges from the first connecting end 211 to the gathering end 212 to seal the proximal or distal opening of the supporting body 10. The braided structure 21 uses braided filaments with a diameter of 0.02mm to 0.06mm; the material is nickel-titanium, cobalt-chromium alloy, etc.; and the number of braided filaments is 24 to 72.
[0039] After the braided structure 21 is pre-formed, it is connected to the support body 10 by welding or other methods. The first connecting end 211 of the braided structure 21 is welded to the near end or far end of the support body 10. Specifically, the braiding end of the braided structure 21 is welded to the braiding end of the support body 10. The manufacturing process of the braided structure 21 can refer to the manufacturing process of the support body 10, and will not be described in detail here.
[0040] It should be noted that although both the support body 10 and the braided structure 21 are formed by braiding filaments, they are braided separately, which makes the braiding density of the braided structure 21 greater than that of the support body 10. The higher braiding density of the braided structure 21 can block the proximal or distal opening of the support body 10, while the lower braiding density of the support body 10 reduces the radial force and pushing resistance when the support body 10 is pushed, thereby reducing the inner diameter of the microcatheter that pushes the support body 10.
[0041] The spring coil structure 22 includes a helical coil 221 and a secondary helical spring coil 222 formed by winding the spring coil along the helical coil 221. The helical coil 221 includes a second connecting end connected to the corresponding opening 11 and a free end opposite to the second connecting end. The free end is located at the center of the helical coil 221.
[0042] Specifically, the spring coil is a platinum-tungsten spring coil, which is a primary helix. The platinum-tungsten spring coil is wound along the helical coil 221 to form a secondary helical spring coil 222. The platinum-tungsten spring coil is fixed to the helical coil 221 by dispensing or welding. The second connecting end of the helical coil 221 is welded to the support body 10. The helical coil 221 is made of materials such as nickel-titanium alloy or cobalt-chromium alloy. The number of turns of the helical coil 221 is 3~20, and the pitch is 0.3mm~3mm. The spring coil wire diameter is 0.001mm~0.1mm, the outer diameter of the primary helix is 0.2mm~1mm, the outer diameter of the secondary helix is 0.8mm~6mm, and the spring coil pitch is 0.1mm~3mm.
[0043] It should be noted that when the aneurysm closure device is implanted, the outer diameter of the maximum outer contour of the spiral coil 221 is greater than the inner diameter of the corresponding opening 11. Since the hardness of the support body 10 is greater than that of the spring coil, when the aneurysm closure device is implanted, the support body 10 slightly compresses the spring coil structure 22, thereby enabling the spring coil structure 22 to completely seal the corresponding opening 11.
[0044] The manufacturing process of the spring coil structure 22 includes the fabrication of the primary helical spring coil, the fabrication of the secondary helical spring coil, the heat setting of the secondary helical spring coil, and the fixing of the secondary helical spring coil onto the helical coil.
[0045] The aneurysm occlusion device also includes a contrast-enhancing band 30 coaxially arranged with the support body 10. The contrast-enhancing band 30 is connected to the end of the occlusion member 20 away from the corresponding opening 11. Two contrast-enhancing bands 30 are provided to respectively match the proximal occlusion member and the distal occlusion member. The two contrast-enhancing bands 30 are a proximal contrast-enhancing band and a distal contrast-enhancing band, respectively. The proximal contrast-enhancing band is connected to the proximal occlusion member, and the distal contrast-enhancing band is connected to the distal occlusion member.
[0046] When the sealing component 20 adopts a braided structure 21, the developing loop 30 is connected to the closed end 212 of the braided structure 21; when the sealing structure 20 adopts a spring coil structure 22, the developing loop 30 is connected to the free end of the spring coil structure 22.
[0047] When the aneurysm occlusion device is implanted, the contrast-enhancing ring 30 is located inside the support body 10. It is understood that when the support body 10 is implanted, the proximal occlusion member gradually converges from the proximal end of the support body 10 towards the proximal contrast-enhancing ring located within the support body 10, thereby causing the proximal occlusion member to indent inward and block the proximal opening of the support body 10; similarly, the distal occlusion member gradually converges from the distal end of the support body 10 towards the distal contrast-enhancing ring located within the support body 10, thereby causing the distal occlusion member to indent inward and block the distal opening of the support body 10.
[0048] The imaging band 30 serves two purposes: firstly, it provides imaging and positioning, allowing observation of the release position of the occlusion member 20 after the aneurysm occlusion device is implanted into the aneurysm; secondly, it allows the occlusion member 20 to be drawn into the imaging band 30, preventing the end of the occlusion member 20 from damaging the aneurysm wall.
[0049] The diameter of the imaging band 30 is 0.1mm~0.3mm and the height is 0.2mm~0.3mm. It is made of gold, tantalum, platinum-iridium alloy or platinum-tungsten alloy, and the imaging band 30 is rounded to prevent damage to the aneurysm wall.
[0050] Reference Figure 3 and Figure 4 In one embodiment, the proximal occlusion member adopts a spring coil structure 22, and the distal occlusion member adopts a braided structure 21. The opening 11 corresponding to the spring coil structure 22 is the proximal opening, and the opening 11 corresponding to the braided structure 21 is the distal opening.
[0051] Reference Figure 3 This diagram illustrates the aneurysm closure device in its implanted state in this embodiment. The spring coil structure 22 can block the proximal opening of the support body 10, that is, block the neck of the aneurysm, forming a first barrier layer to prevent blood from entering the aneurysm. The braided structure 21 can block the distal opening of the support body 10, forming a second barrier layer to prevent the outflow of any small amount of blood that has entered the support body 10 through the spring coil structure 22, further improving the closure effect.
[0052] Reference Figure 4 This diagram illustrates the aneurysm occlusion device in its delivery state in this embodiment. At this time, the aneurysm occlusion device is located within the guide sheath or microcatheter, the support body 10 is compressed and contracted, and the braided structure 21 is housed within the support body 10. The contrast ring 30 connected to the braided structure 21 is located within the support body 10. It should be noted that before placing the aneurysm occlusion device within the guide sheath or microcatheter, the proximal contrast ring (i.e., the contrast ring 30 connected to the spring coil structure 22) located inside the support body 10 needs to be pulled out to the outside of the support body 10. This straightens the spiral coil 221, and simultaneously restores the secondary spiral spring coil 222 to its primary spiral state. This allows the aneurysm occlusion device to be delivered using a smaller diameter guide sheath or microcatheter. A smaller diameter guide sheath or microcatheter has a smaller contact area with blood, allowing it to reach a greater distance from the blood vessel, facilitating high-precision delivery. Simultaneously, the straightened spring coil structure 22 experiences less pushing resistance, making it easier to operate.
[0053] Reference Figure 5 and Figure 6In another embodiment, the proximal occlusion member adopts a braided structure 21, and the distal occlusion member adopts a spring coil structure 22. The opening 11 corresponding to the spring coil structure 22 is the distal opening, and the opening 11 corresponding to the braided structure 21 is the proximal opening.
[0054] Reference Figure 5 This diagram illustrates the aneurysm closure device in its implanted state in this embodiment. The braided structure 21 can seal the proximal opening of the support body 10, that is, seal the neck of the aneurysm, forming a first barrier layer to prevent blood from entering the aneurysm. The spring coil structure 22 can seal the distal opening of the support body 10, forming a second barrier layer to prevent the outflow of any small amount of blood that has entered the support body 10 through the braided structure 21, further improving the closure effect.
[0055] Reference Figure 6 This diagram illustrates the aneurysm occlusion device in its delivery state in this embodiment. At this time, the aneurysm occlusion device is located within the guide sheath or microcatheter, the support body 10 is compressed and contracted, and the braided structure 21 is housed within the support body 10. The contrast ring 30 connected to the braided structure 21 is located within the support body 10. It should be noted that before placing the aneurysm occlusion device within the guide sheath or microcatheter, the distal contrast ring (i.e., the contrast ring 30 connected to the spring coil structure 22) located inside the support body 10 needs to be pulled out to the outside of the support body 10. This straightens the spiral coil 221, and simultaneously restores the secondary spiral spring coil 222 to its primary spiral state. This allows the aneurysm occlusion device to be delivered using a smaller diameter guide sheath or microcatheter. A smaller diameter guide sheath or microcatheter has a smaller contact area with blood, allowing it to reach a greater distance from the blood vessel, facilitating high-precision delivery. Simultaneously, the straightened spring coil structure 22 experiences less pushing resistance, making it easier to operate.
[0056] Reference Figure 7 and Figure 8 In another embodiment, both the proximal occlusion member and the distal occlusion member adopt a braided structure 21.
[0057] Reference Figure 7 This diagram illustrates the aneurysm closure device in its implanted state in this embodiment. The proximal braided structure 21 seals the proximal opening of the support body 10, i.e., it seals the neck of the aneurysm, forming a first barrier layer to prevent blood from entering the aneurysm. The distal braided structure 21 seals the distal opening of the support body 10, forming a second barrier layer to prevent any small amount of blood entering the support body 10 through the proximal braided structure 21 from flowing out, further improving the closure effect.
[0058] Reference Figure 8This is a schematic diagram of the aneurysm occlusion device in the delivery state in this embodiment. At this time, the aneurysm occlusion device is located in the guide sheath or microcatheter, the support body 10 is compressed and contracted, and the braided structures 21 at the proximal and distal ends are both housed inside the support body 10. The proximal imaging bundle ring and the distal imaging bundle ring are both located inside the support body 10.
[0059] Reference Figure 9 and Figure 10 In another embodiment, both the proximal occlusion member and the distal occlusion member adopt a spring coil structure 22.
[0060] Reference Figure 9 This diagram illustrates the aneurysm closure device in its implanted state in this embodiment. The proximal spring coil structure 22 can block the proximal opening of the support body 10, that is, block the neck of the aneurysm, forming a first barrier layer to prevent blood from entering the aneurysm. The distal spring coil structure 22 can block the distal opening of the support body 10, forming a second barrier layer to prevent the outflow of any small amount of blood that has entered the support body 10 through the proximal spring coil structure 22, further improving the closure effect.
[0061] Reference Figure 10 This is a schematic diagram of the support body 10 in the delivery state in this embodiment. At this time, the aneurysm occlusion device is located inside the guide sheath or microcatheter, and the support body 10 is compressed and contracted. It should be noted that before placing the aneurysm occlusion device in the guide sheath or microcatheter, the contrast ring 30 located inside the support body 10 needs to be pulled out to the outside of the support body 10, thereby straightening the spiral coils 221 of the proximal and distal spring coil structures 22. At the same time, the secondary spiral spring coil 222 is restored to the primary spiral. In this way, the aneurysm occlusion device can be delivered using a guide sheath or microcatheter with a smaller diameter. The smaller diameter guide sheath or microcatheter has a smaller contact surface area with blood, which can reach a farther location in the blood vessel, making it easier to achieve high positioning. At the same time, the straightened spring coil structure 22 has less pushing resistance and is easier to operate.
[0062] The support body 10 has several braided endpoints surrounding an opening 11. The aneurysm closure device also includes a radiopaque ball 40 disposed at the braided endpoints. The radiopaque ball 40 serves two purposes: firstly, it provides radiopaque contrast to observe the implantation location of the support body 10; secondly, it prevents the ends of the braided wires of the support body 10 from damaging the aneurysm wall. The radiopaque ball 40 has a diameter of 0.05 mm to 0.1 mm and is made of gold, tantalum, platinum-iridium alloy, or platinum-tungsten alloy. It is fused onto the braided endpoints of the support body 10 using a laser fusion ball process.
[0063] It should be noted that when the sealing component 20 adopts a braided structure 21, the braiding density of the braided structure 21 is greater than that of the support body 10, resulting in a greater number of braided endpoints in the braided structure 21 than in the support body 10. As a result, when the braided structure 21 is welded to the support body 10, some braided endpoints of the braided structure 21 will not be welded to the braided endpoints of the support body 10, and these braided endpoints will be exposed. To prevent these braided endpoints from damaging the aneurysm wall, a contrasting ball 40 can also be placed at these braided endpoints.
[0064] In summary, this invention facilitates the connection of the sealing member 20 to the proximal and distal ends of the support body 10 by providing openings 11 at both ends. Furthermore, when the aneurysm closure device is implanted, the sealing member 20 can be recessed into the support body 10 without obstruction. By simultaneously providing the sealing member 20 at both the proximal and distal ends of the support body 10, after the aneurysm closure device is implanted into the aneurysm, both the proximal and distal openings of the support body 10 are sealed by the sealing member 20, achieving double-layer sealing to prevent blood from flowing into the aneurysm and improving the sealing effect. The distal sealing member is recessed into the support body 10, preventing it from touching and puncturing the aneurysm, thus protecting the aneurysm from rupture. The proximal sealing member is recessed into the support body 10, preventing it from protruding into the carrier artery. The proximal sealing member does not affect the blood flow in the carrier artery, thus preventing thrombosis and the risk of vascular blockage.
[0065] It should be understood that although this specification describes embodiments, not every embodiment contains only one independent technical solution. This way of describing the specification is only for clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment can also be appropriately combined to form other embodiments that can be understood by those skilled in the art.
[0066] The detailed descriptions listed above are merely specific descriptions of feasible embodiments of the present utility model and are not intended to limit the scope of protection of the present utility model. All equivalent embodiments or modifications made without departing from the spirit of the present utility model should be included within the scope of protection of the present utility model.
Claims
1. An aneurysm occlusion device, having a delivery state and an implantation state, characterized in that, include: The support body (10) is a radially expandable mesh structure, and the proximal and distal ends of the support body (10) have openings (11). Two sealing components (20) are respectively connected to the proximal and distal ends of the support body (10); When the aneurysm occlusion device is in the implanted state, the occlusion member (20) blocks the corresponding opening (11), and the occlusion member (20) is recessed into the interior of the support body (10).
2. The aneurysm occlusion device according to claim 1, characterized in that: Both of the sealing components (20) adopt a braided structure (21); or, both of the sealing components (20) adopt a spring coil structure (22); or, one of the two sealing components (20) adopts a braided structure (21) and the other adopts a spring coil structure (22).
3. The aneurysm occlusion device according to claim 2, characterized in that: The braided structure (21) includes a first connecting end (211) connected to the corresponding opening (11) and a gathering end (212) opposite to the first connecting end (211). The braided structure (21) gradually gathers from the first connecting end (211) to the gathering end (212). When the aneurysm occlusion device is in the delivery state, the braided structure (21) is located inside the support body (10).
4. The aneurysm occlusion device according to claim 2, characterized in that: The spring coil structure (22) includes a helical coil (221) and a secondary helical spring coil (222) formed by winding the spring coil along the helical coil (221). The helical coil (221) includes a second connecting end connected to the corresponding opening (11) and a free end opposite to the second connecting end. When the aneurysm occlusion device is in the delivery state, the spring coil structure (22) is located outside the support body (10), and the spiral coil (221) is in a straightened state.
5. The aneurysm occlusion device according to claim 4, characterized in that: When the aneurysm closure device is implanted, the maximum outer diameter of the spiral coil (221) is greater than the inner diameter of the corresponding opening (11).
6. The aneurysm occlusion device according to claim 3 or 4, characterized in that: It also includes a developing beam ring (30) coaxially disposed with the support body (10), the developing beam ring (30) being connected to the end of the sealing member (20) away from the corresponding opening (11).
7. The aneurysm occlusion device according to claim 1, characterized in that: When the aneurysm occlusion device is implanted, the ratio of the depth of the occlusion member (20) to the height of the support body (10) is 1 / 5 to 2 / 5.
8. The aneurysm occlusion device according to claim 1, characterized in that: The support body (10) includes a first part (12) and a second part (13) located at the proximal end of the first part (12). When the aneurysm closure device is implanted, from the proximal end to the distal end of the support body (10), the outer diameter of the second part (13) gradually increases, the outer diameter of the first part (12) gradually decreases, and the height of the first part (12) is less than the height of the second part (13).
9. The aneurysm occlusion device according to claim 8, characterized in that: When the aneurysm closure device is implanted, the ratio of the height of the first part (12) to the maximum outer diameter of the support body (10) is 1 / 8 to 1 / 6; the ratio of the height of the second part (13) to the maximum outer diameter of the support body (10) is 1 / 4 to 3 / 8.
10. The aneurysm occlusion device according to claim 1, characterized in that: The support body (10) is formed by braiding filaments, which include a nickel-titanium tube and a developing filament located inside the nickel-titanium tube; or, the braiding filaments are made of nickel-titanium wire and developing filaments. The support body (10) has a plurality of braided ends surrounding the opening (11), and the aneurysm occlusion device further includes a radiopaque ball (40) disposed at the braided ends.
